Primary |
Atrial Fibrillation |
66.7% |
Drug Use For Unknown Indication |
11.1% |
Hypertension |
11.1% |
Thrombosis Prophylaxis |
11.1% |
|
Optic Atrophy |
12.5% |
Pneumonitis |
12.5% |
Spider Naevus |
12.5% |
Staphylococcal Infection |
12.5% |
Toxicity To Various Agents |
12.5% |
Tremor |
12.5% |
Vasculitis |
12.5% |
Ventricular Hypertrophy |
12.5% |
|
Secondary |
Product Used For Unknown Indication |
25.4% |
Myocardial Ischaemia |
16.9% |
Arrhythmia |
9.9% |
Drug Use For Unknown Indication |
9.9% |
Supraventricular Tachycardia |
7.0% |
Atrial Fibrillation |
5.6% |
Multiple Myeloma |
4.2% |
Atrial Flutter |
2.8% |
Urinary Tract Infection |
2.8% |
Antibiotic Prophylaxis |
1.4% |
Cardioversion |
1.4% |
Depression |
1.4% |
Endoscopy |
1.4% |
Epilepsy |
1.4% |
Gout |
1.4% |
Grand Mal Convulsion |
1.4% |
Heart Rate Irregular |
1.4% |
Hypertension |
1.4% |
Hypothyroidism |
1.4% |
Initial Insomnia |
1.4% |
|
Torsade De Pointes |
12.5% |
Renal Failure Acute |
8.3% |
White Blood Cell Count Decreased |
8.3% |
Atrial Fibrillation |
4.2% |
Gastrointestinal Haemorrhage |
4.2% |
Hallucination |
4.2% |
International Normalised Ratio Increased |
4.2% |
Multiple Drug Overdose |
4.2% |
Presyncope |
4.2% |
Rash Pruritic |
4.2% |
Respiratory Failure |
4.2% |
Sexual Dysfunction |
4.2% |
Sinus Bradycardia |
4.2% |
Skin Oedema |
4.2% |
Syncope |
4.2% |
Tachyarrhythmia |
4.2% |
Therapy Non-responder |
4.2% |
Transaminases Increased |
4.2% |
Transient Ischaemic Attack |
4.2% |
Tricuspid Valve Incompetence |
4.2% |
|
Concomitant |
Drug Use For Unknown Indication |
17.0% |
Acute Myeloid Leukaemia |
9.8% |
Multiple Myeloma |
9.8% |
Plasma Cell Myeloma |
7.1% |
Non-small Cell Lung Cancer |
6.3% |
Product Used For Unknown Indication |
5.4% |
Prophylaxis |
5.4% |
Septic Shock |
4.5% |
Atrial Fibrillation |
3.6% |
Gait Disturbance |
3.6% |
Stem Cell Transplant |
3.6% |
Benign Prostatic Hyperplasia |
2.7% |
Blood Cholesterol Increased |
2.7% |
Cardiac Failure |
2.7% |
Chronic Lymphocytic Leukaemia |
2.7% |
Chronic Myeloid Leukaemia |
2.7% |
Colitis |
2.7% |
Hypertension |
2.7% |
Metastatic Renal Cell Carcinoma |
2.7% |
Pulmonary Arterial Hypertension |
2.7% |
|
Vomiting |
12.5% |
Thrombocytopenia |
8.9% |
Renal Failure Acute |
7.1% |
Pain |
5.4% |
Pneumonia |
5.4% |
Septic Shock |
5.4% |
Somnolence |
5.4% |
Ventricular Fibrillation |
5.4% |
Ventricular Tachycardia |
5.4% |
Atrial Fibrillation |
3.6% |
Cardiac Arrest |
3.6% |
Haemoglobin Decreased |
3.6% |
Multiple Sclerosis Relapse |
3.6% |
Osteoarthritis |
3.6% |
Post Procedural Complication |
3.6% |
Rash |
3.6% |
Renal Failure Chronic |
3.6% |
Right Ventricular Failure |
3.6% |
Splenomegaly |
3.6% |
Sudden Death |
3.6% |
|